Skip to main content
Top
Published in: Cancer Cell International 1/2014

Open Access 01-12-2014 | Primary research

The RelB alternative NF-kappaB subunit promotes autophagy in 22Rv1 prostate cancer cells in vitro and affects mouse xenograft tumor growth in vivo

Authors: Ingrid Labouba, Alexis Poisson, Julie Lafontaine, Nathalie Delvoye, Philippe O Gannon, Cécile Le Page, Fred Saad, Anne-Marie Mes-Masson

Published in: Cancer Cell International | Issue 1/2014

Login to get access

Abstract

Background

The involvement of NF-κB signaling in prostate cancer (PCa) has largely been established through the study of the classical p65 subunit. Nuclear localization of p65 in PCa patient tissues has been shown to correlate with biochemical recurrence, while in vitro studies have demonstrated that the classical NF-κB signaling pathway promotes PCa progression and metastatic potential. More recently, the nuclear location of RelB, a member of the alternative NF-κB signaling, has also been shown to correlate with the Gleason score. The current study aims to clarify the role of alternative NF-κB in PCa cells by exploring, in vitro and in vivo, the effects of RelB overexpression on PCa biology.

Methods

Using a lentivirus-expression system, we constitutively overexpressed RelB or control GFP into 22Rv1 cells and monitored alternative transcriptional NF-κB activity. In vivo, tumor growth was assessed after the injection of 22Rv1-derived cells into SCID mice. In vitro, the impact of RelB on 22Rv1 cell proliferation was evaluated in monolayer culture. The anchorage-independent cell growth of derived-22Rv1 cells was assessed by soft agar assay. Apoptosis and autophagy were evaluated by Western blot analysis in 22Rv1-derived cells cultured in suspension using poly-HEMA pre-coated dishes.

Results

The overexpression of RelB in 22Rv1 cells induced the constitutive activation of the alternative NF-κB pathway. In vivo, RelB expression caused a lag in the initiation of 22Rv1-induced tumors in SCID mice. In vitro, RelB stimulated the proliferation of 22Rv1 cells and reduced their ability to grow in soft agar. These observations may be reconciled by our findings that, when cultured in suspension on poly-HEMA pre-coated dishes, 22Rv1 cells expressing RelB were more susceptible to cell death, and more specifically to autophagy controlled death.

Conclusions

This study highlights a role of the alternative NF-κB pathway in proliferation and the controlled autophagy. Thus, the interplay of these properties may contribute to tumor survival in stress conditions while promoting PCa cells growth contributing to the overall tumorigenicity of these cells.
Appendix
Available only for authorised users
Literature
1.
go back to reference Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 2012, 62 (1): 10-29. 10.3322/caac.20138.CrossRefPubMed Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 2012, 62 (1): 10-29. 10.3322/caac.20138.CrossRefPubMed
2.
go back to reference Pomerantz M, Kantoff P: Advances in the treatment of prostate cancer. Annu Rev Med. 2007, 58: 205-220. 10.1146/annurev.med.58.101505.115650.CrossRefPubMed Pomerantz M, Kantoff P: Advances in the treatment of prostate cancer. Annu Rev Med. 2007, 58: 205-220. 10.1146/annurev.med.58.101505.115650.CrossRefPubMed
3.
go back to reference Domingo-Domenech J, Mellado B, Ferrer B, Truan D, Codony-Servat J, Sauleda S, Alcover J, Campo E, Gascon P, Rovira A, Ross JS, Fernandez PL, Albanell J: Activation of nuclear factor-kappaB in human prostate carcinogenesis and association to biochemical relapse. Br J Cancer. 2005, 93 (11): 1285-1294. 10.1038/sj.bjc.6602851.CrossRefPubMedCentralPubMed Domingo-Domenech J, Mellado B, Ferrer B, Truan D, Codony-Servat J, Sauleda S, Alcover J, Campo E, Gascon P, Rovira A, Ross JS, Fernandez PL, Albanell J: Activation of nuclear factor-kappaB in human prostate carcinogenesis and association to biochemical relapse. Br J Cancer. 2005, 93 (11): 1285-1294. 10.1038/sj.bjc.6602851.CrossRefPubMedCentralPubMed
4.
go back to reference Fradet V, Lessard L, Begin LR, Karakiewicz P, Masson AM, Saad F: Nuclear factor-kappaB nuclear localization is predictive of biochemical recurrence in patients with positive margin prostate cancer. Clin Cancer Res. 2004, 10 (24): 8460-8464. 10.1158/1078-0432.CCR-04-0764.CrossRefPubMed Fradet V, Lessard L, Begin LR, Karakiewicz P, Masson AM, Saad F: Nuclear factor-kappaB nuclear localization is predictive of biochemical recurrence in patients with positive margin prostate cancer. Clin Cancer Res. 2004, 10 (24): 8460-8464. 10.1158/1078-0432.CCR-04-0764.CrossRefPubMed
5.
go back to reference Ismail HA, Lessard L, Mes-Masson AM, Saad F: Expression of NF-kappaB in prostate cancer lymph node metastases. Prostate. 2004, 58 (3): 308-313. 10.1002/pros.10335.CrossRefPubMed Ismail HA, Lessard L, Mes-Masson AM, Saad F: Expression of NF-kappaB in prostate cancer lymph node metastases. Prostate. 2004, 58 (3): 308-313. 10.1002/pros.10335.CrossRefPubMed
6.
go back to reference Lessard L, Karakiewicz PI, Bellon-Gagnon P, Alam-Fahmy M, Ismail HA, Mes-Masson AM, Saad F: Nuclear localization of nuclear factor-kappaB p65 in primary prostate tumors is highly predictive of pelvic lymph node metastases. Clin Cancer Res. 2006, 12 (19): 5741-5745. 10.1158/1078-0432.CCR-06-0330.CrossRefPubMed Lessard L, Karakiewicz PI, Bellon-Gagnon P, Alam-Fahmy M, Ismail HA, Mes-Masson AM, Saad F: Nuclear localization of nuclear factor-kappaB p65 in primary prostate tumors is highly predictive of pelvic lymph node metastases. Clin Cancer Res. 2006, 12 (19): 5741-5745. 10.1158/1078-0432.CCR-06-0330.CrossRefPubMed
7.
go back to reference Lessard L, Mes-Masson AM, Lamarre L, Wall L, Lattouf JB, Saad F: NF-kappa B nuclear localization and its prognostic significance in prostate cancer. BJU Int. 2003, 91 (4): 417-420. 10.1046/j.1464-410X.2003.04104.x.CrossRefPubMed Lessard L, Mes-Masson AM, Lamarre L, Wall L, Lattouf JB, Saad F: NF-kappa B nuclear localization and its prognostic significance in prostate cancer. BJU Int. 2003, 91 (4): 417-420. 10.1046/j.1464-410X.2003.04104.x.CrossRefPubMed
8.
go back to reference McCall P, Bennett L, Ahmad I, Mackenzie LM, Forbes IW, Leung HY, Sansom OJ, Orange C, Seywright M, Underwood MA, Edwards J: NFκB signalling is upregulated in a subset of castrate-resistant prostate cancer patients and correlates with disease progression. Br J Cancer. 2012, 107 (9): 1554-1563. 10.1038/bjc.2012.372.CrossRefPubMedCentralPubMed McCall P, Bennett L, Ahmad I, Mackenzie LM, Forbes IW, Leung HY, Sansom OJ, Orange C, Seywright M, Underwood MA, Edwards J: NFκB signalling is upregulated in a subset of castrate-resistant prostate cancer patients and correlates with disease progression. Br J Cancer. 2012, 107 (9): 1554-1563. 10.1038/bjc.2012.372.CrossRefPubMedCentralPubMed
9.
go back to reference Ross JS, Kallakury BV, Sheehan CE, Fisher HA, Kaufman RP, Kaur P, Gray K, Stringer B: Expression of nuclear factor-kappa B and I kappa B alpha proteins in prostatic adenocarcinomas: correlation of nuclear factor-kappa B immunoreactivity with disease recurrence. Clin Cancer Res. 2004, 10 (7): 2466-2472. 10.1158/1078-0432.CCR-0543-3.CrossRefPubMed Ross JS, Kallakury BV, Sheehan CE, Fisher HA, Kaufman RP, Kaur P, Gray K, Stringer B: Expression of nuclear factor-kappa B and I kappa B alpha proteins in prostatic adenocarcinomas: correlation of nuclear factor-kappa B immunoreactivity with disease recurrence. Clin Cancer Res. 2004, 10 (7): 2466-2472. 10.1158/1078-0432.CCR-0543-3.CrossRefPubMed
10.
go back to reference Perkins ND: The diverse and complex roles of NF-kappaB subunits in cancer. Nat Rev Cancer. 2012, 12 (2): 121-132.PubMed Perkins ND: The diverse and complex roles of NF-kappaB subunits in cancer. Nat Rev Cancer. 2012, 12 (2): 121-132.PubMed
11.
go back to reference Gilmore TD: Introduction to NF-kappaB: players, pathways, perspectives. Oncogene. 2006, 25 (51): 6680-6684. 10.1038/sj.onc.1209954.CrossRefPubMed Gilmore TD: Introduction to NF-kappaB: players, pathways, perspectives. Oncogene. 2006, 25 (51): 6680-6684. 10.1038/sj.onc.1209954.CrossRefPubMed
13.
go back to reference Lessard L, Begin LR, Gleave ME, Mes-Masson AM, Saad F: Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study. Br J Cancer. 2005, 93 (9): 1019-1023. 10.1038/sj.bjc.6602796.CrossRefPubMedCentralPubMed Lessard L, Begin LR, Gleave ME, Mes-Masson AM, Saad F: Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study. Br J Cancer. 2005, 93 (9): 1019-1023. 10.1038/sj.bjc.6602796.CrossRefPubMedCentralPubMed
14.
go back to reference Xu Y, Fang F, St Clair DK, St Clair WH: Inverse relationship between PSA and IL-8 in prostate cancer: an insight into a NF-kappaB-mediated mechanism. PLoS One. 2012, 7 (3): e32905-10.1371/journal.pone.0032905.CrossRefPubMedCentralPubMed Xu Y, Fang F, St Clair DK, St Clair WH: Inverse relationship between PSA and IL-8 in prostate cancer: an insight into a NF-kappaB-mediated mechanism. PLoS One. 2012, 7 (3): e32905-10.1371/journal.pone.0032905.CrossRefPubMedCentralPubMed
15.
go back to reference Xu Y, Josson S, Fang F, Oberley TD, St Clair DK, Wan XS, Sun Y, Bakthavatchalu V, Muthuswamy A, St Clair WH: RelB enhances prostate cancer growth: implications for the role of the nuclear factor-kappaB alternative pathway in tumorigenicity. Cancer Res. 2009, 69 (8): 3267-3271. 10.1158/0008-5472.CAN-08-4635.CrossRefPubMedCentralPubMed Xu Y, Josson S, Fang F, Oberley TD, St Clair DK, Wan XS, Sun Y, Bakthavatchalu V, Muthuswamy A, St Clair WH: RelB enhances prostate cancer growth: implications for the role of the nuclear factor-kappaB alternative pathway in tumorigenicity. Cancer Res. 2009, 69 (8): 3267-3271. 10.1158/0008-5472.CAN-08-4635.CrossRefPubMedCentralPubMed
16.
go back to reference Demicco EG, Kavanagh KT, Romieu-Mourez R, Wang X, Shin SR, Landesman-Bollag E, Seldin DC, Sonenshein GE: RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland. Mol Cell Biol. 2005, 25 (22): 10136-10147. 10.1128/MCB.25.22.10136-10147.2005.CrossRefPubMedCentralPubMed Demicco EG, Kavanagh KT, Romieu-Mourez R, Wang X, Shin SR, Landesman-Bollag E, Seldin DC, Sonenshein GE: RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland. Mol Cell Biol. 2005, 25 (22): 10136-10147. 10.1128/MCB.25.22.10136-10147.2005.CrossRefPubMedCentralPubMed
17.
go back to reference Wang X, Belguise K, Kersual N, Kirsch KH, Mineva ND, Galtier F, Chalbos D, Sonenshein GE: Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2. Nat Cell Biol. 2007, 9 (4): 470-478. 10.1038/ncb1559.CrossRefPubMedCentralPubMed Wang X, Belguise K, Kersual N, Kirsch KH, Mineva ND, Galtier F, Chalbos D, Sonenshein GE: Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2. Nat Cell Biol. 2007, 9 (4): 470-478. 10.1038/ncb1559.CrossRefPubMedCentralPubMed
18.
go back to reference Holley AK, Xu Y, St Clair DK, St Clair WH: RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells. Ann N Y Acad Sci. 2010, 1201: 129-136. 10.1111/j.1749-6632.2010.05613.x.CrossRefPubMedCentralPubMed Holley AK, Xu Y, St Clair DK, St Clair WH: RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells. Ann N Y Acad Sci. 2010, 1201: 129-136. 10.1111/j.1749-6632.2010.05613.x.CrossRefPubMedCentralPubMed
19.
go back to reference Mineva ND, Wang X, Yang S, Ying H, Xiao ZX, Holick MF, Sonenshein GE: Inhibition of RelB by 1,25-dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation. J Cell Physiol. 2009, 220 (3): 593-599. 10.1002/jcp.21765.CrossRefPubMedCentralPubMed Mineva ND, Wang X, Yang S, Ying H, Xiao ZX, Holick MF, Sonenshein GE: Inhibition of RelB by 1,25-dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation. J Cell Physiol. 2009, 220 (3): 593-599. 10.1002/jcp.21765.CrossRefPubMedCentralPubMed
20.
go back to reference Campeau E, Ruhl VE, Rodier F, Smith CL, Rahmberg BL, Fuss JO, Campisi J, Yaswen P, Cooper PK, Kaufman PD: A versatile viral system for expression and depletion of proteins in mammalian cells. PLoS One. 2009, 4 (8): e6529-10.1371/journal.pone.0006529.CrossRefPubMedCentralPubMed Campeau E, Ruhl VE, Rodier F, Smith CL, Rahmberg BL, Fuss JO, Campisi J, Yaswen P, Cooper PK, Kaufman PD: A versatile viral system for expression and depletion of proteins in mammalian cells. PLoS One. 2009, 4 (8): e6529-10.1371/journal.pone.0006529.CrossRefPubMedCentralPubMed
21.
go back to reference Lafontaine J, Rodier F, Ouellet V, Mes-Masson AM: Necdin, a p53-target gene, is an inhibitor of p53-mediated growth arrest. PLoS One. 2012, 7 (2): e31916-10.1371/journal.pone.0031916.CrossRefPubMedCentralPubMed Lafontaine J, Rodier F, Ouellet V, Mes-Masson AM: Necdin, a p53-target gene, is an inhibitor of p53-mediated growth arrest. PLoS One. 2012, 7 (2): e31916-10.1371/journal.pone.0031916.CrossRefPubMedCentralPubMed
22.
go back to reference Rodier F, Coppe JP, Patil CK, Hoeijmakers WA, Munoz DP, Raza SR, Freund A, Campeau E, Davalos AR, Campisi J: Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol. 2009, 11 (8): 973-979. 10.1038/ncb1909.CrossRefPubMedCentralPubMed Rodier F, Coppe JP, Patil CK, Hoeijmakers WA, Munoz DP, Raza SR, Freund A, Campeau E, Davalos AR, Campisi J: Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol. 2009, 11 (8): 973-979. 10.1038/ncb1909.CrossRefPubMedCentralPubMed
23.
go back to reference Le Page C, Koumakpayi IH, Alam-Fahmy M, Mes-Masson AM, Saad F: Expression and localisation of Akt-1, Akt-2 and Akt-3 correlate with clinical outcome of prostate cancer patients. Br J Cancer. 2006, 94 (12): 1906-1912. 10.1038/sj.bjc.6603184.CrossRefPubMedCentralPubMed Le Page C, Koumakpayi IH, Alam-Fahmy M, Mes-Masson AM, Saad F: Expression and localisation of Akt-1, Akt-2 and Akt-3 correlate with clinical outcome of prostate cancer patients. Br J Cancer. 2006, 94 (12): 1906-1912. 10.1038/sj.bjc.6603184.CrossRefPubMedCentralPubMed
24.
go back to reference Lessard L, Saad F, Le Page C, Diallo JS, Peant B, Delvoye N, Mes-Masson AM: NF-kappaB2 processing and p52 nuclear accumulation after androgenic stimulation of LNCaP prostate cancer cells. Cell Signal. 2007, 19 (5): 1093-1100. 10.1016/j.cellsig.2006.12.012.CrossRefPubMed Lessard L, Saad F, Le Page C, Diallo JS, Peant B, Delvoye N, Mes-Masson AM: NF-kappaB2 processing and p52 nuclear accumulation after androgenic stimulation of LNCaP prostate cancer cells. Cell Signal. 2007, 19 (5): 1093-1100. 10.1016/j.cellsig.2006.12.012.CrossRefPubMed
25.
go back to reference Le Page C, Koumakpayi IH, Lessard L, Mes-Masson AM, Saad F: EGFR and Her-2 regulate the constitutive activation of NF-kappaB in PC-3 prostate cancer cells. Prostate. 2005, 65 (2): 130-140. 10.1002/pros.20234.CrossRefPubMed Le Page C, Koumakpayi IH, Lessard L, Mes-Masson AM, Saad F: EGFR and Her-2 regulate the constitutive activation of NF-kappaB in PC-3 prostate cancer cells. Prostate. 2005, 65 (2): 130-140. 10.1002/pros.20234.CrossRefPubMed
26.
go back to reference Taddei ML, Giannoni E, Fiaschi T, Chiarugi P: Anoikis: an emerging hallmark in health and diseases. J Pathol. 2012, 226 (2): 380-393. 10.1002/path.3000.CrossRefPubMed Taddei ML, Giannoni E, Fiaschi T, Chiarugi P: Anoikis: an emerging hallmark in health and diseases. J Pathol. 2012, 226 (2): 380-393. 10.1002/path.3000.CrossRefPubMed
27.
go back to reference Chiarugi P, Giannoni E: Anoikis: a necessary death program for anchorage-dependent cells. Biochem Pharmacol. 2008, 76 (11): 1352-1364. 10.1016/j.bcp.2008.07.023.CrossRefPubMed Chiarugi P, Giannoni E: Anoikis: a necessary death program for anchorage-dependent cells. Biochem Pharmacol. 2008, 76 (11): 1352-1364. 10.1016/j.bcp.2008.07.023.CrossRefPubMed
28.
go back to reference Guadamillas MC, Cerezo A, Del Pozo MA: Overcoming anoikis–pathways to anchorage-independent growth in cancer. J Cell Sci. 2011, 124 (Pt 19): 3189-3197.CrossRefPubMed Guadamillas MC, Cerezo A, Del Pozo MA: Overcoming anoikis–pathways to anchorage-independent growth in cancer. J Cell Sci. 2011, 124 (Pt 19): 3189-3197.CrossRefPubMed
29.
go back to reference Horbinski C, Mojesky C, Kyprianou N: Live free or die: tales of homeless (cells) in cancer. Am J Pathol. 2010, 177 (3): 1044-1052. 10.2353/ajpath.2010.091270.CrossRefPubMedCentralPubMed Horbinski C, Mojesky C, Kyprianou N: Live free or die: tales of homeless (cells) in cancer. Am J Pathol. 2010, 177 (3): 1044-1052. 10.2353/ajpath.2010.091270.CrossRefPubMedCentralPubMed
30.
go back to reference Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y, Yoshimori T: LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000, 19 (21): 5720-5728. 10.1093/emboj/19.21.5720.CrossRefPubMedCentralPubMed Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y, Yoshimori T: LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000, 19 (21): 5720-5728. 10.1093/emboj/19.21.5720.CrossRefPubMedCentralPubMed
31.
go back to reference Dumont P, Petein M, Lespagnard L, Tueni E, Coune A: Unusual behaviour of the LNCaP prostate tumour xenografted in nude mice. In Vivo. 1993, 7 (2): 167-170.PubMed Dumont P, Petein M, Lespagnard L, Tueni E, Coune A: Unusual behaviour of the LNCaP prostate tumour xenografted in nude mice. In Vivo. 1993, 7 (2): 167-170.PubMed
32.
go back to reference Stephenson RA, Dinney CP, Gohji K, Ordonez NG, Killion JJ, Fidler IJ: Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J Natl Cancer Inst. 1992, 84 (12): 951-957. 10.1093/jnci/84.12.951.CrossRefPubMed Stephenson RA, Dinney CP, Gohji K, Ordonez NG, Killion JJ, Fidler IJ: Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J Natl Cancer Inst. 1992, 84 (12): 951-957. 10.1093/jnci/84.12.951.CrossRefPubMed
33.
go back to reference Sramkoski RM, Pretlow TG, Giaconia JM, Pretlow TP, Schwartz S, Sy MS, Marengo SR, Rhim JS, Zhang D, Jacobberger JW: A new human prostate carcinoma cell line, 22Rv1. In Vitro Cell Dev Biol Anim. 1999, 35 (7): 403-409. 10.1007/s11626-999-0115-4.CrossRefPubMed Sramkoski RM, Pretlow TG, Giaconia JM, Pretlow TP, Schwartz S, Sy MS, Marengo SR, Rhim JS, Zhang D, Jacobberger JW: A new human prostate carcinoma cell line, 22Rv1. In Vitro Cell Dev Biol Anim. 1999, 35 (7): 403-409. 10.1007/s11626-999-0115-4.CrossRefPubMed
34.
go back to reference Peant B, Diallo JS, Lessard L, Delvoye N, Le Page C, Saad F, Mes-Masson AM: Regulation of IkappaB kinase epsilon expression by the androgen receptor and the nuclear factor-kappaB transcription factor in prostate cancer. Mol Cancer Res. 2007, 5 (1): 87-94. 10.1158/1541-7786.MCR-06-0144.CrossRefPubMed Peant B, Diallo JS, Lessard L, Delvoye N, Le Page C, Saad F, Mes-Masson AM: Regulation of IkappaB kinase epsilon expression by the androgen receptor and the nuclear factor-kappaB transcription factor in prostate cancer. Mol Cancer Res. 2007, 5 (1): 87-94. 10.1158/1541-7786.MCR-06-0144.CrossRefPubMed
35.
go back to reference Skjoth IH, Issinger OG: Profiling of signaling molecules in four different human prostate carcinoma cell lines before and after induction of apoptosis. Int J Oncol. 2006, 28 (1): 217-229.PubMed Skjoth IH, Issinger OG: Profiling of signaling molecules in four different human prostate carcinoma cell lines before and after induction of apoptosis. Int J Oncol. 2006, 28 (1): 217-229.PubMed
37.
go back to reference Copetti T, Bertoli C, Dalla E, Demarchi F, Schneider C: p65/RelA modulates BECN1 transcription and autophagy. Mol Cell Biol. 2009, 29 (10): 2594-2608. 10.1128/MCB.01396-08.CrossRefPubMedCentralPubMed Copetti T, Bertoli C, Dalla E, Demarchi F, Schneider C: p65/RelA modulates BECN1 transcription and autophagy. Mol Cell Biol. 2009, 29 (10): 2594-2608. 10.1128/MCB.01396-08.CrossRefPubMedCentralPubMed
38.
go back to reference Copetti T, Demarchi F, Schneider C: p65/RelA binds and activates the beclin 1 promoter. Autophagy. 2009, 5 (6): 858-859. 10.4161/auto.8822.CrossRefPubMed Copetti T, Demarchi F, Schneider C: p65/RelA binds and activates the beclin 1 promoter. Autophagy. 2009, 5 (6): 858-859. 10.4161/auto.8822.CrossRefPubMed
39.
go back to reference Nivon M, Richet E, Codogno P, Arrigo AP, Kretz-Remy C: Autophagy activation by NFkappaB is essential for cell survival after heat shock. Autophagy. 2009, 5 (6): 766-783. 10.4161/auto.8788.CrossRefPubMed Nivon M, Richet E, Codogno P, Arrigo AP, Kretz-Remy C: Autophagy activation by NFkappaB is essential for cell survival after heat shock. Autophagy. 2009, 5 (6): 766-783. 10.4161/auto.8788.CrossRefPubMed
40.
go back to reference Hippert MM, O’Toole PS, Thorburn A: Autophagy in cancer: good, bad, or both?. Cancer Res. 2006, 66 (19): 9349-9351. 10.1158/0008-5472.CAN-06-1597.CrossRefPubMed Hippert MM, O’Toole PS, Thorburn A: Autophagy in cancer: good, bad, or both?. Cancer Res. 2006, 66 (19): 9349-9351. 10.1158/0008-5472.CAN-06-1597.CrossRefPubMed
41.
go back to reference Eskelinen EL: Doctor Jekyll and Mister Hyde: autophagy can promote both cell survival and cell death. Cell Death Differ. 2005, 12 (Suppl 2): 1468-1472.CrossRefPubMed Eskelinen EL: Doctor Jekyll and Mister Hyde: autophagy can promote both cell survival and cell death. Cell Death Differ. 2005, 12 (Suppl 2): 1468-1472.CrossRefPubMed
42.
go back to reference Ferraro E, Cecconi F: Autophagic and apoptotic response to stress signals in mammalian cells. Arch Biochem Biophys. 2007, 462 (2): 210-219. 10.1016/j.abb.2007.02.006.CrossRefPubMed Ferraro E, Cecconi F: Autophagic and apoptotic response to stress signals in mammalian cells. Arch Biochem Biophys. 2007, 462 (2): 210-219. 10.1016/j.abb.2007.02.006.CrossRefPubMed
43.
go back to reference Desgrosellier JS, Barnes LA, Shields DJ, Huang M, Lau SK, Prevost N, Tarin D, Shattil SJ, Cheresh DA: An integrin alpha (v)beta(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression. Nat Med. 2009, 15 (10): 1163-1169. 10.1038/nm.2009.CrossRefPubMedCentralPubMed Desgrosellier JS, Barnes LA, Shields DJ, Huang M, Lau SK, Prevost N, Tarin D, Shattil SJ, Cheresh DA: An integrin alpha (v)beta(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression. Nat Med. 2009, 15 (10): 1163-1169. 10.1038/nm.2009.CrossRefPubMedCentralPubMed
44.
go back to reference Zhong X, Rescorla FJ: Cell surface adhesion molecules and adhesion-initiated signaling: understanding of anoikis resistance mechanisms and therapeutic opportunities. Cell Signal. 2012, 24 (2): 393-401. 10.1016/j.cellsig.2011.10.005.CrossRefPubMed Zhong X, Rescorla FJ: Cell surface adhesion molecules and adhesion-initiated signaling: understanding of anoikis resistance mechanisms and therapeutic opportunities. Cell Signal. 2012, 24 (2): 393-401. 10.1016/j.cellsig.2011.10.005.CrossRefPubMed
Metadata
Title
The RelB alternative NF-kappaB subunit promotes autophagy in 22Rv1 prostate cancer cells in vitro and affects mouse xenograft tumor growth in vivo
Authors
Ingrid Labouba
Alexis Poisson
Julie Lafontaine
Nathalie Delvoye
Philippe O Gannon
Cécile Le Page
Fred Saad
Anne-Marie Mes-Masson
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2014
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/1475-2867-14-67

Other articles of this Issue 1/2014

Cancer Cell International 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine